Anti-Inflammatory Effect of Kamebakaurin in in vivo Animal Models

 

 Buy Article Permissions and Reprints

Abstract

We have identified kamebakaurin as an inhibitor of NF-κB and elucidated its molecular mechanism as a specific inhibitor in the DNA-binding activity of the p50 subunit of NF-κB. Here, we describe its anti-inflammatory activity in in vitro and in vivo models. Kamebakaurin dose-dependently inhibited not only the expression of inflammatory NF-κB target genes such as iNOS, COX-2, and TNF-α, but also the production of PGE₂ and TNF-α in LPS-stimulated RAW264.7 cells. Moreover, in an air pouch model of inflammation, it suppressed the recruitment of neutrophils, production of TNF-α as well as PGE₂ in the pouch exudates induced by carrageenan. In addition, kamebakaurin dose-dependently suppressed the inflammation in an adjuvant arthritis model. Oral administration of 20 mg/kg kamebakaurin resulted in the 75 % decrease of paw volume. Taken together, kamebakaurin, a specific inhibitor of DNA-binding activity of the p50 subunit, is a valuable candidate for the intervention in NF-κB-dependent pathological conditions such as inflammation.

References

• 1 Baldwin A S. The NF-κB and IκB proteins: new discoveries and insights.  Annu Rev Immunol. 1996;  14 649-81
  CrossrefPubMedGoogle Scholar
• 2 Ghosh S, May M J, Kopp E B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses.  Annu Rev Immunol. 1998;  16 225-60
  CrossrefPubMedGoogle Scholar
• 3 Barkett M, Gilmore T D. Control of apoptosis by Rel/NF-kappaB transcription factors.  Oncogene. 1999;  18 6910-24
  CrossrefPubMedGoogle Scholar
• 4 Wang C Y, Mayo M W, Korneluk R G, Goeddel D V, Baldwin A S. NF-κB anti-apoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.  Science. 1998;  281 1680-3
  CrossrefPubMedGoogle Scholar
• 5 Baeuerle P A, Baltimore D A. 65-kD subunit of active NF-κB is required for inhibition of NF-κB by IκB.  Genes Dev. 1989;  3 1689-98
  PubMedGoogle Scholar
• 6 Ballard D W, Dixon E P, Peffer N J, Bogerd H, Doerre S, Stein B, Greene W C. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and a target for v-Rel-mediated repression.  Proc Natl Acad Sci USA. 1992;  89 1875-9
  PubMedGoogle Scholar
• 7 Schmitz M L, Baeuerle P. The p65 subunit is responsible for the strong transcription activating potential of NF-κB.  EMBO J. 1991;  10 3805-17
  PubMedGoogle Scholar
• 8 Pahl H L. Activators and target genes of Rel/NF-κB transcription factors.  Oncogene. 1999;  18 6853-66
  CrossrefPubMedGoogle Scholar
• 9 Yamamoto Y, Gaynor R B. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer.  J Clin Invest. 2001;  107 135-42
  PubMedGoogle Scholar

Jung Joon Lee

Anticancer Research Laboratory

Korea Research Institute of Bioscience and Biotechnology

P.O. Box 115

Yuseong

Daejeon 305-600

Korea

Phone: +82-42-860-4360

Fax: +82-42-860-4595

Email: jjlee@kribb.re.kr